Ana Mingorance
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Baseline characteristics and feasibility of clinical outcome measures in CDKL5 deficiency disorder: The CANDID observational study.
Journal: Epilepsia
Published: August 11, 2025
Gene therapies for neurogenetic disorders.
Journal: Trends in molecular medicine
Published: November 18, 2024
The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study.
Journal: Frontiers in neurology
Published: June 21, 2022
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder.
Journal: Frontiers in neurology
Published: July 01, 2021
Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.
Journal: Scientific reports
Published: April 14, 2021
Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches.
Journal: Orphanet journal of rare diseases
Published: March 31, 2021
Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective.
Journal: Epilepsia
Published: April 23, 2020
Diagnostic gap in genetic epilepsies: A matter of age.
Journal: Epilepsy & behavior : E&B
Published: February 26, 2020
Analysis of the family impact and needs of Dravet's syndrome in Spain
Journal: Revista de neurologia
Published: January 30, 2020
Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.
Journal: Epilepsy currents
Published: January 16, 2020
Drivers of Orphan Drug Development.
Journal: ACS medicinal chemistry letters
Published: October 23, 2018
Last Updated: 09/26/2026